Form 8-K - Current report:
SEC Accession No. 0001193125-14-110536
Filing Date
2014-03-21
Accepted
2014-03-21 17:04:23
Documents
3
Period of Report
2014-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d698060d8k.htm 8-K 15544
2 EX-99.1 d698060dex991.htm EX-99.1 28743
3 GRAPHIC g698060img1.jpg GRAPHIC 7320
  Complete submission text file 0001193125-14-110536.txt   55738
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 14710877
SIC: 2834 Pharmaceutical Preparations